Dermatology clinical trials recruiting in Texas

53 recruiting dermatology trials match in Texas. Showing 20.

• Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and PsoriasisRecruiting

  Phase 1 · LAPIX Therapeutics Inc. · Dallas, Texas

• A Study of Zasocitinib in Adults With Nonsegmental VitiligoRecruiting

  Phase 2 · Takeda · Bellaire, Texas

• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental VitiligoRecruiting

  Phase 3 · Incyte Corporation · Austin, Texas

• A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Enveda Therapeutics · Dallas, Texas

• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentRecruiting

  N/A · Sanofi · Dallas, Texas

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Dallas, Texas

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisRecruiting

  Phase 3 · Janssen Research & Development, LLC · Dallas, Texas

• A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoRecruiting

  Phase 2 · Eli Lilly and Company · Humble, Texas

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Arlington, Texas

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Baytown, Texas

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Dallas, Texas

• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 / Phase 3 · Bluefin Biomedicine, Inc. · Prosper, Texas

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · San Antonio, Texas

• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic DermatitisRecruiting

  Phase 2 · Novartis Pharmaceuticals · Arlington, Texas

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · San Antonio, Texas

• A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne ScarsRecruiting

  Phase 3 · AbbVie · Pflugerville, Texas

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · Colleyville, Texas

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Houston, Texas

• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Inmagene LLC · Southlake, Texas

• Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo PatientsRecruiting

  Phase 2 · Elixiron Immunotherapeutics (Hong Kong) Ltd. · Houston, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.